Search research articles
Contact Us
Filters
Showing results (1151-1160 of 1,173) with videos related to
Page
of 118
Sort By:
Biorxiv : the Preprint Server for Biology
|
January 4, 2022
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
Sabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Pain
|
July 10, 2012
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations
Dennis C Turk, Alec B O'Connor, Robert H Dworkin, et al.
Neuro-Oncology
|
July 5, 2022
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus
Peter M K de Blank, Andrea M Gross, Srivandana Akshintala, et al.
Scientific Reports
|
December 29, 2019
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector
M Giel-Moloney, M Esteban, B H Oakes, et al.
Emerging Infectious Diseases
|
February 24, 2022
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers
Eric D Laing, Carol D Weiss, Emily C Samuels, et al.
Nature
|
November 5, 2025
Lymphoid gene expression supports neuroprotective microglia function
Pinar Ayata, Jessica M Crowley, Matthew F Challman, et al.
Drug and Alcohol Dependence
|
April 16, 2024
Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial
LaShawn Glasgow, Christian Douglas, Joel G Sprunger, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Craters on the melanoma surface facilitate tumor-immune interactions and demonstrate pathologic response to checkpoint blockade in humans
Aya Ludin, Georgia L Stirtz, Asaf Tal, et al.
Cell Host & Microbe
|
November 10, 2022
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history
Wei Wang, Sabrina Lusvarghi, Rahul Subramanian, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera
Barbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Page
of 118
Search research articles
Search
Showing results (1151-1160 of 1,173) with videos related to
Sort By:
Page
of 118
Biorxiv : the Preprint Server for Biology
|
January 4, 2022
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
Sabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Pain
|
July 10, 2012
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations
Dennis C Turk, Alec B O'Connor, Robert H Dworkin, et al.
Neuro-Oncology
|
July 5, 2022
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus
Peter M K de Blank, Andrea M Gross, Srivandana Akshintala, et al.
Scientific Reports
|
December 29, 2019
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector
M Giel-Moloney, M Esteban, B H Oakes, et al.
Emerging Infectious Diseases
|
February 24, 2022
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers
Eric D Laing, Carol D Weiss, Emily C Samuels, et al.
Nature
|
November 5, 2025
Lymphoid gene expression supports neuroprotective microglia function
Pinar Ayata, Jessica M Crowley, Matthew F Challman, et al.
Drug and Alcohol Dependence
|
April 16, 2024
Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial
LaShawn Glasgow, Christian Douglas, Joel G Sprunger, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Craters on the melanoma surface facilitate tumor-immune interactions and demonstrate pathologic response to checkpoint blockade in humans
Aya Ludin, Georgia L Stirtz, Asaf Tal, et al.
Cell Host & Microbe
|
November 10, 2022
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history
Wei Wang, Sabrina Lusvarghi, Rahul Subramanian, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera
Barbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Page
of 118